This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Ensign Group Rewards Shareholders With 4.2% Dividend Hike
by Zacks Equity Research
ENSG hikes quarterly dividend by 4.2%, maintaining its record of raising dividends for the past 22 years.
Centene Unveils Its 2025 Guidance, Reaffirms 2024 Outlook
by Zacks Equity Research
CNC expects robust growth in its Medicaid, Marketplace and Medicare businesses. This is likely to be driven by rate increases, rising uninsured individuals and dual expansions.
Should Value Investors Buy Encompass Health (EHC) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Community Health to Divest North Carolina Hospital for $280M
by Zacks Equity Research
CYH is selling the 123-bed facility in Mooresville to Duke Health.
EHC or CHE: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
EHC vs. CHE: Which Stock Is the Better Value Option?
Brookdale's 37-Month Growth Streak: Is BKD Stock a Safe Bet?
by Zacks Equity Research
BKD's weighted average occupancy for November grows 10 bps sequentially.
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Here's Why Encompass Health (EHC) is a Strong Growth Stock
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Community Health Unit Northwest Urgent Closes Arizona Buyouts
by Zacks Equity Research
CYH's acquisition expands Northwest Healthcare arm's network to more than 80 care sites.
Encompass Health Up 60% in a Year: What Lies Ahead for Investors?
by Zacks Equity Research
EHC remains well-poised for growth on the back of solid discharge growth, an aging U.S. population, frequent expansion initiatives and strong cash reserves.
Why Is Encompass Health (EHC) Up 3.8% Since Last Earnings Report?
by Zacks Equity Research
Encompass Health (EHC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Are Investors Undervaluing Encompass Health (EHC) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Select Medical Distributes Concentra Shares to Shareholders
by Zacks Equity Research
By separating from Concentra, which specializes in occupational health services, SEM can better allocate resources to its primary segments.
EHC vs. CHE: Which Stock Is the Better Value Option?
by Zacks Equity Research
EHC vs. CHE: Which Stock Is the Better Value Option?
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Compelling Reasons to Hold on to Ensign Group Stock Now
by Zacks Equity Research
ENSG drives revenue growth through advanced healthcare services, strategic acquisitions, and rental income from triple-net leases, supported by strong cash reserves and a 21-year dividend growth streak.
Tenet Healthcare Partners With Commure for Ambient AI Platform
by Zacks Equity Research
THC actively invests in selected AI-enabled technologies, which are expected to enhance the clinical and administrative workflow and efficiency.
Why Encompass Health (EHC) is a Top Growth Stock for the Long-Term
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
JYNT's Q3 Earnings Meet Estimates Amid Higher Costs, Shares Dip 3%
by Zacks Equity Research
The Joint's Q3 results reflect higher general and administrative costs. Revenues benefit from strong royalty fees and advertising revenues.
Should Value Investors Buy Encompass Health (EHC) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Pediatrix Medical Stock Soars 30.5% Since Q3 Earnings Beat
by Zacks Equity Research
MD expects transformational and restructuring-related expenses to be $48 million in 2024.
EHC or ASTH: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
EHC vs. ASTH: Which Stock Is the Better Value Option?
Encompass Health Corporation (EHC) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Encompass Health (EHC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Teladoc Health Q3 Loss Narrows on Strong Integrated Care Unit
by Zacks Equity Research
TDOC expects 2024 U.S. Integrated Care Members to remain within 93.5-94.5 million.
Encompass Health (EHC) is a Top-Ranked Value Stock: Should You Buy?
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.